{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "585",
                "651"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wrodzona wada serca pod postaci\u0105 ubytku w przegrodzie przedsionk\u00f3w"
        },
        {
            "identifier": "T2",
            "position": [
                "346",
                "355"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Cefazolin"
        },
        {
            "icd": "ICD10:Q21.1",
            "identifier": "N1",
            "referenced": "T1",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzyprzedsionkowej"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 11 miesi\u0119cy\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nCefazolin.\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: ICD10:Q21.1|Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wrodzona wada serca pod postaci\u0105 ubytku w przegrodzie przedsionk\u00f3w.\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:14.74[10\\\\^3/ul]\n    RBC:5.37[10\\\\^6/ul]\n    HGB:12.4[g/dl]\n    HCT:35.0[%]\n    MCV:65.2[fl]\n    MCH:23.1[pg]\n    MCHC:35.4[g/dl]\n    PLT:529.0[10\\\\^3/ul]\n    RDW-SD:45.9[fl]\n    RDW-CV:20.5[%]\n    PDW:9.5[fl]\n    MPV:8.8[fl]\n    P-LCR:17.0[%]\n    PCT:0.5[%]\n    NEUTR#:2.38[10\\\\^3/ul]\n    NEUTR%:16.2[%]\n    LYMPH#:10.17[10\\\\^3/ul]\n    LYMPH%:69.0[%]\n    MONO#:0.93[10\\\\^3/ul]\n    MONO%:6.30[%]\n    EO#:1.15[10\\\\^3/ul]\n    EO%:7.80[%]\n    BASO#:0.11[10\\\\^3/ul]\n    BASO%:0.70[%]\n    NRBC %:0.10[%]\n    NRBC#:0.02[10\\\\^3/ul]\nImmununochemia -Immulite: COMMENT_HL7:\nKoagulologia: COMMENT_HL7:\nD-dimery t. ilo\u015bciowy: D-dimer:1547.0[ng/ml]\nFibrynogen (F): FIB:1.92[g/L]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:53.5[s]\nINR: INR:1.0\nCzas protrombinowy (PT): PT:11.4[s]\nCzas trombinowy (TT): TT:17.6[s]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:96[%]\nKreatynina: CREA:0.40[mg/dl]\nMocznik: UREA:28.00[mg/dl]\nASPAT: AST:51.00[IU/L]\nALAT: ALT:36.00[IU/L]\nNT- proBNP: NTpBNP:396.00[pg/ml]\nWzrost pacjenta: WzrostPac:68[cm]\neGFR (do 1r\u017c) wg Schwartza wsp. 0.413: eGFRdo1r\u017c:70.2[ml/min/1,73m2]\n------------------------------------------------\nICD10\n------------------------------------------------\nQ21.1\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n89.00\n87.440\n------------------------------------------------"
}